Mild cognitive impairment in Parkinson’s disease: the Parkinson’s disease cognitive study (PACOS)

Journal of Neurology

Volumn 265, Issue 5, 2018, Pages 1050-1058

  Monastero, Roberto ^a   Cicero, Calogero Edoardo ^b   Baschi, Roberta ^a   Davì, Marco ^a   Luca, Antonina ^b   Restivo, Vincenzo ^a   Zangara, Chiara ^b   Fierro, Brigida ^a   Zappia, Mario ^b   Nicoletti, Alessandra ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Cognitive impairment; Epidemiology; Parkinson s disease; Prevalence

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

AGED; ARTICLE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE DURATION; FEMALE; HOEHN AND YAHR SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; UNIFIED PARKINSON DISEASE RATING SCALE; AMNESIA; CLINICAL TRIAL; COMPLICATION; EDUCATIONAL STATUS; MULTIVARIATE ANALYSIS; ODDS RATIO; ONSET AGE; PSYCHOLOGY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

AGE OF ONSET; AGED; AMNESIA; COGNITIVE DYSFUNCTION; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; ODDS RATIO; PARKINSON DISEASE; PREVALENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 85042405570     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-018-8800-4     Document Type: Article

References (47)

1. Williams-Gray CH, Mason SL, Evans JR et al (2013) The CamPaIGN study of Parkinson’s disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry 84:1258–1264
2. Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256:183–194
3. Litvan I, Goldman JG, Tröster AI et al (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: movement Disorder Society Task Force guidelines. Mov Disord 27:349–356
4. Pedersen KF, Larsen JP, Tysnes OB, Alves G (2013) Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian Park West Study. JAMA Neurol 70:580–586
5. Lawrence BJ, Gasson N, Loftus AM (2016) Prevalence and subtypes of mild cognitive impairment in Parkinson’s disease. Sci Rep 6:33929. 10.1038/srep33929
6. Cholerton BA, Zabetian CP, Wan JY et al (2014) Evaluation of mild cognitive impairment subtypes in Parkinson’s disease: MCI subtypes in Parkinson’s disease. Mov Disord 29:756–764
7. Aarsland D, Creese B, Politis M et al (2017) Cognitive decline in Parkinson disease. Nat Rev Neurol 13:217–231
8. Pedersen KF, Larsen JP, Tysnes OB, Alves G (2017) Natural course of mild cognitive impairment in Parkinson disease: a 5-year population-based study. Neurology 88:767–774
9. Domellöf ME, Ekman U, Forsgren L, Elgh E (2015) Cognitive function in the early phase of Parkinson’s disease, a five-year follow-up. Acta Neurol Scand 132:79–88
10. Hoogland J, Boel JA, de Bie RMA et al MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease” (2017) Mild cognitive impairment as a risk factor for Parkinson’s disease dementia: MCI as a risk factor for Parkinson’s disease dementia. Mov Disord 32:1056–1065
11. Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:745–752
12. Emre M, Aarsland D, Brown R et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707
13. Fahn S, Elton RL, the members of the UPDRS development committee (1987) Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB (eds) Recent developments in Parkinson’s disease. MacMillan, London, pp 153–163
14. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17:427–442
15. Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC (2013) How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson’s disease rating scale. Mov Disord 28:668–670
16. Folstein MF, Folstein SE, McHugh PR (1975) ‘Mini-mental state’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
17. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 185:914–919
18. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566–572
19. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
20. Schrag A, Barone P, Brown RG et al (2007) Depression rating scales in Parkinson’s disease: critique and recommendations. Mov Disord 22:1077–1092
21. Novelli G, Papagno C, Capitani E et al (1986) Tre test clinici di memoria verbale a lungo termine: Taratura su soggetti normali. Arch Psicol Neurol Psichiatria 47:278–296
22. Novelli G, Papagno C, Capitani E et al (1986) Tre test clinici di ricerca e produzione lessicale. Taratura su soggetti normali. Archivio di Psicologia, Neurologia e Psichiatria 47:477–506
23. Spinnler H, Tognoni G (1987) Italian Group on the Neuropsychological Study of Ageing: Italian standardization and classification of neuropsychological tests. Ital J NeurolSci 6(suppl 8):1–120
24. Luzzatti C, Willmes K, De Bleser R et al (1994) New normative data for the Italian version of the Aachen Aphasia Test (AAT). Arch Psicol Neurol Psichiatria 55:1086–1131
25. Carlesimo GA, Caltagirone C, Gainotti G (1996) The Mental Deterioration Battery: normative data, diagnostic reliability and quantitative analyses of cognitive impairment. Eur Neurol 36:378–384
26. Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E (1996) Trail making test: normative values from 287 normal adult controls. Ital J Neurol Sci 17:305–309
27. Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A (2002) Una versione abbreviata del test di Stroop: dati normativi nella popolazione Italiana. Nuova Riv Neurol 12:111–115
28. Appollonio I, Leone M, Isella V et al (2005) The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci 26:108–116
29. Caffarra P, Gardini S, Zonato F et al (2011) Italian norms for the Freedman version of the Clock Drawing Test. J Clin Exp Neuropsychol 33:982–988
30. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25:2649–2653
31. Litvan I, Aarsland D, Adler CH et al (2011) MDS task force on mild cognitive impairment in Parkinson’s disease: critical review of PD–MCI. Mov Disord 26:1814–1824
32. Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G, Norwegian ParkWest Study Group (2009) Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study. Neurology 72:1121–1126
33. Monastero R, Di Fiore P, Ventimiglia GD et al (2012) Prevalence and profile of mild cognitive impairment in Parkinson’s disease. Neurodegener Dis 10:187–190
34. Goldman JG, Holden S, Bernard B, Ouyang B, Goetz CG, Stebbins GT (2013) Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson’s disease. Mov Disord 28:1972–1979
35. Marras C, Armstrong MJ, Meaney CA et al (2013) Measuring mild cognitive impairment in patients with Parkinson’s disease. Mov Disord 28:626–633
36. Cholerton BA, Zabetian CP, Quinn JF et al (2013) Pacific Northwest Udall Center of excellence clinical consortium: study design and baseline cohort characteristics. J Park Dis 3:205–214
37. Yarnall AJ, Breen DP, Duncan GW et al (2014) Characterizing mild cognitive impairment in incident Parkinson disease The ICICLE-PD Study. Neurology 82:308–316
38. Cereda E, Cilia R, Klersy C et al (2016) Dementia in Parkinson’s disease: is male gender a risk factor? Parkinsonism Relat Disord 26:67–72
39. Hu MTM, Szewczyk-Królikowski K, Tomlinson P et al (2014) Predictors of cognitive impairment in an early stage Parkinson’s disease cohort. Mov Disord 29:351–359
40. Schrag A, Siddiqui UF, Anastasiou Z, Weintraub D, Schott JM (2017) Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson’s disease: a cohort study. Lancet Neurol 16:66–75
41. Zhu K, van Hilten JJ, Marinus J (2014) Predictors of dementia in Parkinson’s disease; findings from a 5-year prospective study using the SCOPA-COG. Parkinsonism Relat Disord 20:980–985
42. Broeders M, De Bie RMA, Velseboer DC, Speelman JD, Muslimovic D, Schmand B (2013) Evolution of mild cognitive impairment in Parkinson disease. Neurology 81:346–352
43. Kalbe E, Rehberg SP, Heber I, Kronenbuerger M et al (2016) Subtypes of mild cognitive impairment in patients with Parkinson’s disease: evidence from the LANDSCAPE study. J Neurol Neurosurg Psychiatry 87:1099–1105
44. Santangelo G, Vitale C, Picillo M et al (2015) Mild Cognitive Impairment in newly diagnosed Parkinson’s disease: a longitudinal prospective study. Parkinsonism Relat Disord 21:1219–1226
45. Anang JB, Gagnon JF, Bertrand JA et al (2014) Predictors of dementia in Parkinson disease: a prospective cohort study. Neurology 83:1253–1260
46. Perez-Lloret S, Barrantes FJ (2016) Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson’s disease. NPJ Parkinson Dis 18(2):16001. 10.1038/npjparkd.2016.1
47. Kehagia AA, Barker RA, Robbins TW (2013) Cognitive impairment in Parkinson’s disease: the dual syndrome hypothesis. Neurodegener Dis 11:79–92